Estrogen mitogenic action. III. Is phenol red a 'red herring'?

In Vitro Cellular and Developmental Biology - Animal

Volumn 36, Issue 7, 2000, Pages 447-464

  Moreno Cuevas, Jorge E ^a   Sirbasku, David A ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Cell growth; Estrogen receptor; Hamster kidney tumor cells; Human breast cancer cells; Human prostate cancer cells; Progesterone receptor; Rat mammary tumor cells; Rat pituitary tumor cells; Serum inhibitor; Tamoxifen

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; PHENOLSULFONPHTHALEIN; PROGESTERONE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL GROWTH; CULTURE MEDIUM; DOSE RESPONSE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYPOPHYSIS TUMOR; KIDNEY TUMOR; MITOGENESIS; NONHUMAN; PROSTATE CANCER; RAT; RECEPTOR BINDING; TISSUE CULTURE;

ANIMALS; BREAST NEOPLASMS; CATTLE; CELL DIVISION; CRICETINAE; CULTURE MEDIA; DRUG CONTAMINATION; ESTRADIOL; ESTROGEN ANTAGONISTS; HORSES; HUMANS; INDICATORS AND REAGENTS; KIDNEY NEOPLASMS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MESOCRICETUS; NEOPLASMS; PHENOLSULFONPHTHALEIN; PITUITARY NEOPLASMS; PROSTATIC NEOPLASMS; RATS; RATS, INBRED WF; RECEPTORS, ESTROGEN; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0033780283     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1290/1071-2690(2000)036<0447:EMAIIP>2.0.CO;2     Document Type: Article

References (121)

1. Growth of a human breast cancer cell line in serum-free hormone-supplemented medium
2. The effects of 17β estradiol and tamoxifen on the ZR-75-1 human breast cancer cell line in defined medium
3. 17β-estradiol has a biphasic effect on GH cell growth
4. Blockade of the epidermal growth factor inhibits transforming growth factor α-induced but not estrogen-induced growth of hormone-dependent human breast cancer
5. Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice
6. Transforming growth factor β: Potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells
7. Serum-free animal cell culture
8. Cellular endocrinology: Integrated physiology in vitro
9. Growth of a human mammary turnout cell line in a serum-free medium
10. Phenol red in tissue culture media is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture
11. Lipophilic impurities, not phenolsulfonphthalein, account for the estrogenic activity in commercial preparations of phenol red
12. Bis(4-hydroxyphenyl)[2-(phenoxysulfonyl)phenyl]methane: Isolation and structural elucidation of a novel estrogen from commercial preparations of phenol red (phenolsulfon-phthalein)
13. Control of cell death (apoptosis) by diethylstilbestrol in an estrogen dependent kidney tumor
14. Effects of serum and insulin on the sensitivity of human breast cancer cell line MCF-7 to estrogen and antiestrogens
15. Steroid stimulation of plasminogen activator production in a human breast cancer cell line (MCF-7)
16. Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor
17. Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D)
18. Scatchard plots: Common errors in correction and interpretation
19. The effects of constitutive expression of transforming growth factor α on growth of MCF-7 human breast cancer cells in vitro and in vivo
20. Growth of MTW9/PL2 estrogen-responsive rat mammary tumor cells in hormonally defined serum-free media
21. New perspectives in hormone-dependent (responsive) and autonomous mammary tumor growth: Role of auto-stimulatory growth factors
22. Effects of estradiol and tamoxifen on breast cancer cells in serum-free culture
23. Effect of estradiol on human breast cancer cells in culture
24. Growth factor-like activity of phenol red preparations in the MCF-7 breast cancer cell line
25. Estrogen conjugates and serum factors mediating the estrogenic trophic effect on MCF-7 cell growth
26. Estrogenic regulation of growth and poly-peptide growth factor secretion in human breast carcinoma
27. Apotransferrin stimulation of thyroid hormone dependent rat pituitary tumor cell growth in serum-free chemically defined medium: Role of Fe(III) chelation
28. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF- 7 human breast cancer cells
29. Estrogen induced synthesis of specific proteins in human breast cancer cells
30. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas
31. Interaction of phenol red with estrogenic and antiestrogenic action on growth of human breast cancer cells ZR-75-1 and T-47-D
32. pH-dependent cytotoxicity of contaminants of phenol red for MCF-7 breast cancer cells
33. Progesterone suppression of estrogen-stimulated prolactin secretion and estrogen receptor levels in rat pituitary cells
34. Effects of sex steroids on prolactin secreting rat pituitary cells in culture
35. LNCaP model of human prostatic carcinoma
36. Lipophilic impurity of phenol red is a potent cation transport modulator
37. + homeostasis of COS-7 cells caused by a lipophilic phenol red impurity
38. Steroid receptor analysis of nine human breast cancer cell lines
39. Multihonnonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells
40. Identification of estrogen-inducible growth factors (estromedins) for rat and human mammary tumor cells in culture
41. Differential responsiveness of the human breast cancer cell lines MCF-7 and T47-D to growth factors and 17β-estradiol
42. Estrogen receptors: Bioactivities and interactions with cell signaling pathways
43. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in short-term and long-term absence of estrogens
44. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells
45. Establishment of a cell line of human breast carcinoma origin
46. Control of cell growth. III. Demonstration of the direct mitogenic effect of thyroid hormones on an estrogen-dependent rat pituitary tumor cell line
47. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells
48. Effects of aliphatic fatty acids on the binding of phenol red to human serum albumin
49. Relations between high-affinity binding sites of markers for binding regions on human serum albumin
50. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands
51. Studies of the endocrine, paracrine, and autocrine control of mammary tumor cell growth
52. Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice
53. Carcinogenicity of catechol estrogens in Syrian hamsters
54. Estrogen-dependent kidney tumors
55. Inhibition of estrogen-induced renal carcinogenesis in male Syrian hamsters by tamoxifen without decrease in DNA adduct levels
56. Oestrugen-responsive human breast cancer in long term tissue culture
57. The effects of estrogen and antiestrogens in hormone-responsive human breast cancer in long-term tissue culture
58. Model systems for the study of estrogen action in tissue culture
59. Expression of transforming growth factor a (TGFα) in differentiated rat mammary tumors: Estrogen induction of TGFα production
60. Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines
61. Frontiers in mammalian cell culture
62. Effects of estradiol on the cell cycle of a rat pituitary tumor cell line containing estrogen receptors
63. Estrogen mitogenic action. I. Demonstration of estrogen-dependent MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in serum supplemented culture and technical implications
64. The 52-kDa estrogen-induced protein secreted by MCF-7 cells is a lysosomal acidic protease
65. Epidermal growth factor expression in human breast cancer cells: Regulation by progestins
66. Uterine insulin-like growth factor-1: Regulation of expression and its role in estrogen-induced uterine proliferation
67. A role for the insulin-like growth factors as estromedins in the rat uterus
68. Two new estrogen-supersensitive variants of the MCF-7 human breast cancer cell line
69. Effect of albumin on the absorption of phenol red, bromphenol blue and bromosulphonphthalein as model drugs from the liver surface membrane in rats
70. A new serum-free method of measuring growth factor activities for human breast cancer cells in culture
71. Insulin-like growth factor-II (IGF-II): A potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor
72. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice
73. Estrogenic effect of phenol red in MCF-7 cells is achieved through activation of estrogen receptor by interacting with a site distinct from the steroid binding site
74. Selective interaction of chemical dyes with inositol 1,4,5-trisphosphate reeognitiou sites
75. Use of serum-free hormonally defined media to evaluate the effects of growth factors and inhibitors on proliferation of estrogen-responsive mammary and pituitary tumor cells in culture
76. Rat pituitary tumor cells in serum-free culture. II. Serum factor and thyroid hormone requirements for estrogen-responsive growth
77. Nonsteroidal antiestrogens are estrogen-receptor-targeted growth inhibitors that can act in the absence of estrogens
78. Estrogen-induced lysosomal proteases secreted by breast cancer cells: A role in carcinogenesis?
79. Iron is deleterious to hormone-responsive pituitary cell growth in serum-free defined medium
80. Apotransferrins from several species promote thyroid hormone-dependent rat pituitary tumor cell growth in iron-restricted serum-free defined culture
81. Estrogen-induced cell multiplication: Direct or indirect effect on rat uterine cells?
82. Effects of interaction between estradiol-17β and progesterone on proliferation of cloned breast cancer cells (MCF-7 and T47D)
83. Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice
84. Estrogen and growth of breast cancer. New evidence suggests indirect action
85. Interaction of phenolsulphonphthalein dyes with rabbit plasma and rabbit serum albumin
86. Estrogen-induction of growth factors specific for estrogen responsive mammary, pituitary and kidney tumor cells
87. Hormone-responsive growth in vivo of a tissue culture cell line established from the MT-W9A rat mammary tumor
88. New concepts in control of estrogen-responsive tumor growth
89. Estrogen-inducible growth factors that may act as mediators (estromedins) of estrogen promoted tumor cell growth
90. Control of cell growth. IV. Growth properties of a new cell line established from an estrogen-dependent tumor of the Syrian hamster
91. Estrogen-inducible growth factors: Proposal of new mechanisms of estrogen-promoted tumor cell growth
92. Estrogen mitogenic action. II. Negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications
93. Serum factor regulation of estrogen responsive mammary tumor cell growth
94. But … are estrogens per se growth promoting hormones
95. Control of cell growth. I. Estrogen-dependent growth in vivo of a rat pituitary tumor cell line
96. Proliferation behavior of the cloned Syrian hamster tumor cells H301
97. P-Nonyl-phenol: An estrogenic xenobiotic released from 'modified' polystyrene
98. Control of cell proliferation: Evidence for negative control on estrogen-sensitive T47D human breast cancer cells
99. Mechanism of estrogen action on cellular proliferation: Evidence for an indirect and negative control on cloned breast tumor cells
100. The roles of estrogens on the proliferation of human breast tumor cells (MCF-7)
101. Control of cell proliferation of estrogen sensitive cells: The case for negative control
102. Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice
103. A human breast cell line from a pleural effusion derived from a breast carcinoma
104. Autocrine secretion and malignant transformation of cells
105. Prolonged retention of estradiol by human breast cancer cells in tissue culture
106. Clonal strains of hormone-producing pituitary cells
107. Production of both prolactin and growth hormone by clonal strains of rat pituitary tumor cells. Differential effects of hydrocortisone and tissue extracts
108. Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone
109. A mutation in the binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens
110. Unusual specificity of the androgen receptor in human prostate tumor cell line LNCaP: High affinity for progestagenic and estrogenic steroids
111. Antiestrogens inhibit the mito-genie effect of growth factors on breast cancer cells in the total absence of estrogens
112. Autocrine growth stimulation of the MCF-7 breast cancer cells by the estrogen-regulated 52K protein
113. Effects of plasma estrogen sulfates in mammary cancer cells
114. Estrogenic activity of phenol red
115. Optimization of estrogen growth response in MCF-7 cells
116. Tissue culture conditions determine the effects of estrogen and growth factors on the anchorage independent growth of human breast cancer cell lines